source
- With $97M, Latus pursues a different kind of Huntington’s gene therapyThe therapy is part of a plan to develop gene therapies that can be efficiently delivered at lower doses, enabling them to be used against more than just “ultra-rare” conditions.BioPharma Dive · 2mo ago↗ source
- UCB to acquire maker of antibody treatments for autoimmune diseasesA second shot at gene therapy for Huntington's, China's tightening grip on pharma supply chains, and more Readout biotech updatesSTAT · 2mo ago↗ source
- What to know about hantavirus, the illness suspected in a cruise ship outbreakA rodent-borne illness is suspected of causing an outbreak aboard a cruise ship that has killed three people and sickened others. Here's what to know about hantavirus.STAT